You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
|
|---|---|
| Published in |
Lancet Oncology, August 2019
|
| DOI | 10.1016/s1470-2045(19)30334-1 |
| Pubmed ID | |
| Authors |
Cristina Saura, Dominik Hlauschek, Mafalda Oliveira, Dimitrios Zardavas, Anita Jallitsch-Halper, Lorena de la Peña, Paolo Nuciforo, Alberto Ballestrero, Peter Dubsky, Janine M Lombard, Peter Vuylsteke, Carlos A Castaneda, Marco Colleoni, Giuliano Santos Borges, Eva Ciruelos, Monica Fornier, Katalin Boer, Aditya Bardia, Timothy R Wilson, Thomas J Stout, Jerry Y Hsu, Yi Shi, Martine Piccart, Michael Gnant, José Baselga, Evandro de Azambuja |
X Demographics
The data shown below were collected from the profiles of 72 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 15% |
| Belgium | 7 | 10% |
| United Kingdom | 6 | 8% |
| Spain | 5 | 7% |
| Mexico | 4 | 6% |
| Austria | 2 | 3% |
| Germany | 2 | 3% |
| Switzerland | 2 | 3% |
| Italy | 2 | 3% |
| Other | 12 | 17% |
| Unknown | 19 | 26% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 38 | 53% |
| Practitioners (doctors, other healthcare professionals) | 19 | 26% |
| Scientists | 12 | 17% |
| Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 210 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 23 | 11% |
| Student > Master | 21 | 10% |
| Researcher | 19 | 9% |
| Student > Ph. D. Student | 17 | 8% |
| Other | 13 | 6% |
| Other | 30 | 14% |
| Unknown | 87 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 30% |
| Biochemistry, Genetics and Molecular Biology | 10 | 5% |
| Nursing and Health Professions | 9 | 4% |
| Agricultural and Biological Sciences | 4 | 2% |
| Psychology | 4 | 2% |
| Other | 19 | 9% |
| Unknown | 100 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2019.
All research outputs
#834,018
of 25,658,541 outputs
Outputs from Lancet Oncology
#1,039
of 6,926 outputs
Outputs of similar age
#17,498
of 357,355 outputs
Outputs of similar age from Lancet Oncology
#27
of 125 outputs
Altmetric has tracked 25,658,541 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,926 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,355 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.